Koninklijke Philips Other Current Assets 2010-2024 | PHG

Koninklijke Philips other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Koninklijke Philips other current assets for the quarter ending September 30, 2024 were $0.769B, a 27.63% increase year-over-year.
  • Koninklijke Philips other current assets for 2023 were $0.627B, a 4.9% increase from 2022.
  • Koninklijke Philips other current assets for 2022 were $0.597B, a 10.47% decline from 2021.
  • Koninklijke Philips other current assets for 2021 were $0.667B, a 37.77% increase from 2020.
Koninklijke Philips Annual Other Current Assets
(Millions of US $)
2023 $627
2022 $597
2021 $667
2020 $484
2019 $576
2018 $657
2017 $1,976
2016 $538
2015 $493
2014 $546
2013 $470
2012 $433
2011 $1,801
2010 $722
2009 $874
Koninklijke Philips Quarterly Other Current Assets
(Millions of US $)
2024-06-30 $769
2023-06-30 $783
2023-03-31
2022-06-30 $913
2021-06-30 $602
2020-06-30 $739
2019-06-30 $615
2018-06-30 $1,323
2017-06-30 $8,085
2016-12-31 $538
2016-09-30 $2,811
2016-06-30 $713
2016-03-31 $2,576
2015-12-31 $493
2015-09-30 $589
2015-06-30 $602
2015-03-31 $606
2014-12-31 $546
2014-09-30 $608
2014-06-30 $615
2014-03-31 $567
2013-12-31 $470
2013-09-30 $563
2013-06-30 $582
2013-03-31 $569
2012-12-31 $489
2012-09-30 $914
2012-06-30 $996
2012-03-31 $1,016
2011-12-31 $1,801
2011-09-30 $2,025
2011-06-30 $1,843
2011-03-31 $1,720
2010-12-31 $722
2010-09-30 $804
2010-06-30 $1,060
2010-03-31 $973
2009-12-31 $874
2009-09-30 $985
2009-06-30 $876
2009-03-31 $918
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.871B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $202.584B 25.84
Stryker (SYK) United States $144.427B 32.55
Boston Scientific (BSX) United States $130.404B 37.49
Medtronic (MDT) Ireland $113.203B 16.84
EssilorLuxottica (ESLOY) France $112.107B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.279B 0.00
Haleon (HLN) United Kingdom $43.049B 27.97
GE HealthCare Technologies (GEHC) United States $39.012B 20.24
ResMed (RMD) United States $36.507B 30.00
Terumo (TRUMY) Japan $30.649B 43.28
Zimmer Biomet Holdings (ZBH) United States $21.791B 13.87
Insulet (PODD) United States $19.339B 77.01
Baxter (BAX) United States $17.458B 11.37
Smith & Nephew SNATS (SNN) United Kingdom $10.816B 0.00
Bio-Rad Laboratories (BIO) United States $10.245B 34.82
BellRing Brands (BRBR) United States $9.218B 38.97
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $5.846B 13.58
TG Therapeutics (TGTX) United States $4.785B 0.00
Haemonetics (HAE) United States $4.590B 22.40
ICU Medical (ICUI) United States $4.354B 41.56
Prestige Consumer Healthcare (PBH) United States $4.039B 20.09
Perrigo (PRGO) Ireland $3.645B 10.73
Envista Holdings (NVST) United States $3.571B 26.60
Neogen (NEOG) United States $3.554B 41.00
Agios Pharmaceuticals (AGIO) United States $3.448B 0.00
GN Store Nord (GNNDY) Denmark $3.068B 19.67
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.891B 18.61
LeMaitre Vascular (LMAT) United States $2.372B 57.65
Warby Parker (WRBY) United States $2.084B 0.00
AtriCure (ATRC) United States $1.862B 0.00
Green Thumb Industries (GTBIF) United States $1.651B 28.90
InMode (INMD) Israel $1.638B 9.85
Maravai LifeSciences Holdings (MRVI) United States $1.458B 0.00
AdaptHealth (AHCO) United States $1.405B 10.05
BioLife Solutions (BLFS) United States $1.227B 0.00
Curaleaf Holdings (CURLF) Canada $1.079B 0.00
Phibro Animal Health (PAHC) United States $1.035B 18.25
Owens & Minor (OMI) United States $1.031B 8.05
CeriBell (CBLL) United States $0.983B 0.00
National Vision Holdings (EYE) United States $0.931B 31.10
Capricor Therapeutics (CAPR) United States $0.887B 0.00
Evolus (EOLS) United States $0.831B 0.00
VAREX IMAGING (VREX) United States $0.598B 18.04
Quanterix (QTRX) United States $0.588B 0.00
Surmodics (SRDX) United States $0.549B 0.00
Verano Holdings (VRNOF) United States $0.546B 0.00
Cresco Labs (CRLBF) United States $0.508B 0.00
Valneva SE (VALN) France $0.417B 0.00
ZimVie (ZIMV) United States $0.394B 33.19
Canopy Growth (CGC) Canada $0.379B 0.00
Cerus (CERS) United States $0.377B 0.00
Viemed Healthcare (VMD) United States $0.370B 35.22
OraSure Technologies (OSUR) United States $0.316B 21.20
Biote (BTMD) United States $0.312B 14.38
Sanara MedTech (SMTI) United States $0.306B 0.00
Zynex (ZYXI) United States $0.296B 62.00
MacroGenics (MGNX) United States $0.276B 0.00
Aurora Cannabis (ACB) Canada $0.262B 0.00
Jin Medical (ZJYL) China $0.250B 0.00
Omeros (OMER) United States $0.249B 0.00
Utah Medical Products (UTMD) United States $0.238B 16.05
High Tide (HITI) Canada $0.213B 88.33
TerrAscend (TSNDF) Canada $0.196B 0.00
Brainsway (BWAY) Israel $0.180B 216.00
Organigram Holdings (OGI) Canada $0.169B 0.00
FitLife Brands (FTLF) United States $0.155B 20.99
Rockwell Medical (RMTI) United States $0.144B 0.00
Zevia PBC (ZVIA) United States $0.140B 0.00
TriSalus Life Sciences (TLSI) United States $0.137B 0.00
Quipt Home Medical (QIPT) United States $0.117B 0.00
Veru (VERU) United States $0.106B 0.00
Fonar (FONR) United States $0.094B 9.76
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.20
Cellectar Biosciences (CLRB) United States $0.086B 0.00
Ayr Wellness (AYRWF) United States $0.081B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.69
Modular Medical (MODD) United States $0.072B 0.00
InterCure (INCR) Israel $0.066B 0.00
Safety Shot (SHOT) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
MariMed (MRMD) United States $0.055B 0.00
Jushi Holdings (JUSHF) United States $0.053B 0.00
Exagen (XGN) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Allurion Technologies (ALUR) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Nephros (NEPH) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
GlucoTrack (GCTK) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.60
SNDL (SNDL) Canada $0.000B 0.00